Surgery Partners, Inc.【SGRY】Cash flow
Market cap
$2.1B
P/E ratio
| 2015/12 | 2016/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Depreciation & amortization | 35 | 40 | 67 | 77 | 95 | 99 | 115 | 118 | 153 |
| Stock-based compensation | 8 | 2 | 9 | 10 | 13 | 17 | 18 | 18 | 33 |
| Cash from operations | 84 | 125 | 145 | 130 | 247 | 87 | 159 | 294 | 300 |
| Capital expenditures | -33 | -39 | -40 | -74 | -43 | -58 | -81 | -89 | -90 |
| Cash from investing | -135 | -185 | -129 | -85 | -88 | -332 | -308 | -226 | -488 |
| Repurchases of common stock | - | - | 2 | - | - | - | - | - | - |
| Proceeds from issuance of term debt, net | 196 | 651 | 283 | 507 | 429 | 299 | 218 | 827 | 1,730 |
| Repayments of term debt | 328 | 473 | 158 | 491 | 216 | 343 | 862 | 807 | 1,279 |
| Cash from financing | 33 | 71 | -6 | -136 | 67 | 316 | 42 | -155 | 262 |
| Free cash flow | |||||||||
| FCF margin (%) |